In the News
Dan G. Duda, DMD, PhD, of the Edwin L. Steele Laboratories for Tumor Biology and Department of Radiation Oncology at Massachusetts General Hospital, is the corresponding author of a paper published in Cancer Immunology Research, “Combination CXCR4 and PD1 Blockade Enhances Intratumoral Dendritic Cell Activation and Immune Responses Against Hepatocellular Carcinoma.”
https://www.massgeneral.org/news/research-spotlight/improving-liver-cancer-outcomes-through-enhanced-immonotherapy
|
Congratulations on this achievement! Each researcher selected has authored multiple Highly Cited Papers™ that rank in the top 1% by citations for their field(s) and publication year in the Web of Science™ over the past decade - indicating exceptional influence in their respective disciplines. This list is then refined with the information that lies beneath, using qualitative analysis, expert judgment and robust quality controls to create the final annual list of Highly Cited Researchers. |
The Asian American Academy of Science and Engineering (AAASE) announced that Rakesh Jain has been elected to the inaugural class of Fellows. This distinguished group of scientists and engineers has been recognized for their exceptional contributions to their respective fields and their commitment to advancing the presence and influence of Asian Americans in science, technology, engineering, and mathematics.
- Approved drugs that were originally shown to normalize blood vessels surrounding tumors (to improve drug delivery to cancer cells) can enhance the delivery of anti-microbial medications to kill tuberculosis bacteria residing in the lungs
- These drugs (bevacizumab and losartan) alone and in combination with anti-microbial agents, promoted anti-bacterial host responses and improved health outcomes in lab models with tuberculosis